CN104274788A - 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 - Google Patents
一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN104274788A CN104274788A CN201410620324.5A CN201410620324A CN104274788A CN 104274788 A CN104274788 A CN 104274788A CN 201410620324 A CN201410620324 A CN 201410620324A CN 104274788 A CN104274788 A CN 104274788A
- Authority
- CN
- China
- Prior art keywords
- parts
- heat
- liver
- damp
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 145
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 230000002969 morbid Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 claims abstract description 55
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 21
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000746375 Andrographis Species 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 239000000829 suppository Substances 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 238000010438 heat treatment Methods 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000002674 ointment Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000011347 resin Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 230000002829 reductive effect Effects 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 229920000742 Cotton Polymers 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- -1 electuary Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 238000007493 shaping process Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 230000000274 adsorptive effect Effects 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000013521 mastic Substances 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 229960000502 poloxamer Drugs 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 241000792859 Enema Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000007920 enema Substances 0.000 claims description 2
- 229940095399 enema Drugs 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 57
- 239000008280 blood Substances 0.000 abstract description 57
- 230000001737 promoting effect Effects 0.000 abstract description 23
- 208000024891 symptom Diseases 0.000 abstract description 15
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000001939 inductive effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 235000011034 Rubus glaucus Nutrition 0.000 abstract description 2
- 244000235659 Rubus idaeus Species 0.000 abstract description 2
- 235000009122 Rubus idaeus Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 210000004696 endometrium Anatomy 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000016811 Biondella Nutrition 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 70
- 201000010099 disease Diseases 0.000 description 67
- 230000000694 effects Effects 0.000 description 43
- 208000002193 Pain Diseases 0.000 description 39
- 230000036407 pain Effects 0.000 description 39
- 231100000614 poison Toxicity 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 29
- 210000003734 kidney Anatomy 0.000 description 28
- 230000001717 pathogenic effect Effects 0.000 description 26
- 208000003251 Pruritus Diseases 0.000 description 21
- 206010046901 vaginal discharge Diseases 0.000 description 21
- 230000007812 deficiency Effects 0.000 description 20
- 201000005630 leukorrhea Diseases 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 19
- 210000001215 vagina Anatomy 0.000 description 19
- 238000012360 testing method Methods 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 15
- 230000002159 abnormal effect Effects 0.000 description 15
- 239000003440 toxic substance Substances 0.000 description 15
- 239000002574 poison Substances 0.000 description 13
- 206010007247 Carbuncle Diseases 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 12
- 230000035619 diuresis Effects 0.000 description 12
- 239000007789 gas Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 210000001015 abdomen Anatomy 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000002147 killing effect Effects 0.000 description 10
- 235000021251 pulses Nutrition 0.000 description 10
- 230000035943 smell Effects 0.000 description 10
- 210000001835 viscera Anatomy 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 9
- 208000033809 Suppuration Diseases 0.000 description 9
- 244000045947 parasite Species 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 201000000736 Amenorrhea Diseases 0.000 description 8
- 206010001928 Amenorrhoea Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000019255 Menstrual disease Diseases 0.000 description 8
- 231100000540 amenorrhea Toxicity 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000001473 noxious effect Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010023126 Jaundice Diseases 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 208000028659 discharge Diseases 0.000 description 7
- 230000004438 eyesight Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000001047 pyretic effect Effects 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 6
- 206010048245 Yellow skin Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 208000014617 hemorrhoid Diseases 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 206010060891 General symptom Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000002175 menstrual effect Effects 0.000 description 5
- 230000003821 menstrual periods Effects 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 239000011800 void material Substances 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010011878 Deafness Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 210000003756 cervix mucus Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000021267 infertility disease Diseases 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 201000003453 lung abscess Diseases 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 230000009965 odorless effect Effects 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 201000002364 leukopenia Diseases 0.000 description 3
- 231100001022 leukopenia Toxicity 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000084 Abdominal pain lower Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001062009 Indigofera Species 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241001062472 Stokellia anisodon Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 239000008738 huangbai Substances 0.000 description 2
- 208000022168 hypermenorrhea Diseases 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 229940100691 oral capsule Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 210000002640 perineum Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 208000023409 throat pain Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NULBHTHMVOCGOE-ZBCCAYPVSA-N 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@H](OC=2C=C3C(C(C=C(O3)C=3C=CC(O)=CC=3)=O)=C(O)C=2)O1 NULBHTHMVOCGOE-ZBCCAYPVSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010048946 Anal abscess Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241001161070 Calomela Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 240000000774 Cunila origanoides Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241001299817 Dictamnus Species 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010051235 Madarosis Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 241000117280 Naematelia aurantialba Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000030373 chronic endometritis Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000001936 exophthalmos Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- STKUCSFEBXPTAY-KCWGXYKVSA-N nuezhenoside Natural products COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=CC)[C@@H]1CC(=O)OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O STKUCSFEBXPTAY-KCWGXYKVSA-N 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 208000016254 weariness Diseases 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗妇女肝火湿热型带下的中药组合物,所述内服药物为:土茯苓10~20份,鸡血藤10~20份,山茱萸10~20份,益母草10~20份,柴胡10~20份,丹参10~20份,莪术10~20份,蒲公英10~20份,黄芩10~20份,女贞子10~20份,覆盆子10~20份,龙胆草10~20份,穿心莲10~20份,丹皮10~20份,黄柏10~20份,车前子10~20份;外用药物为:苦参10~20份,蛇床子10~20份,土茯苓10~20份,白鲜皮10~20份,艾叶10~20份,青黛10~20份,鱼腥草10~20份,冰片10~20份。本发明具有清热利湿、益气消瘀功效,用于治疗湿热阻滞导致的下腹痛、白带增多与色黄质稠、腰骶酸痛及神疲乏力等症状;利湿祛风、消散瘀血功效;本发明各味用药清补结合、气血同治,最终达到促进气血和调、子宫内膜修复和提高机体免疫力的目的。
Description
技术领域
本发明涉及含有来源于植物组份的医用配制品,特别涉及一种治疗妇女肝火型带下的中药组合物及其制备方法。
背景技术
带下病是指带下绵绵不断,量多腥臭,色泽异常,并伴有全身症状者,称‘带下病’,带下病症见从阴道流出白色液体,或经血漏下挟有白色液体,淋沥不断,质稀如水者,称之为“白带”。
带下的量明显增多,色、质、气味发生异常,或伴全身、局部症状者,称为“带下病”,又称“下白物”、“流秽物”。相当于西医学的阴道炎、子宫颈炎、盆腔炎、妇科肿瘤等疾病引起的带下增多。
正常女子自青春期开始,肾气充盛,脾气健运,任脉通调,带脉健固,阴道内即有少量白色或无色透明无臭的粘性液体,特别是在经期前后、月经中期及妊娠期量增多,以润泽阴户,防御外邪,此为生理性带下。如《沈氏女科辑要》引王孟英说:“带下,女子生而即有,津津常润,本非病也。”若带下量明显增多,或色、质、气味异常,即为带下病。《女科证治约旨》说:“若外感六淫,内伤七情,酝酿成病,致带脉纵弛,不能约束诸脉经,于是阴中有物,淋漓下降,绵绵不断,即所谓带下也。
该病发生的病因病机主要是脏腑功能失常,湿从内生;或下阴直接感染湿毒虫邪,致使湿邪损伤任带,使任脉不固,带脉失约,带浊下注胞中,流溢于阴窍,发为带下病。
带下病的辨证有虚实之分。临床以实证较多,尤其合并阴痒者更为多见。一般带下量多、色白,质清无臭者,属虚;带下量多,色、质异常有臭者,属实。该病的治疗以祛湿为主。脾虚者,健脾益气,升阳除湿;肾虚者,补肾固涩,佐以健脾除湿;湿热者,清热利湿;湿毒者,清热解毒利湿;感虫阴痒蚀烂者,必须配合阴道冲洗和纳药等外治法
清著名妇科中医经典著作《傅青主女科》认为,带下病主要是带脉受伤害,原因是脾气虚弱,肝气郁积,湿气侵入及热气急逼所引起,因而认为带下病大多是湿证,是湿热侵入胞宫、阴器,累及任脉和带脉,使任脉失固,带脉失约而导致妇女发病。由此得出带下病的病位在任、带二脉,与脾、肾二脏关系密切。脾为中州后天之本,喜燥恶湿。如因饮食不节,劳作失度,或思虑抑郁致土衰木郁,水谷精微失于健运,停聚而成水湿之邪下流肝肾,浸及冲任致带脉失其约束遂成本病。再者肾为先天之根,中寓命门相火,乃元气之宅。凡因先天不足,肾气素虚,或房劳多产伤及下元是阴液滑脱走失于下窍也可酿成带下病。
肝火湿热型白带表现在白带量多、颜色黄、有臭味、舌苔黄腻、月经量增多或延长。临床常见本症带下,脾肾虚寒痰湿越重则带下越甚。危重者状如崩冲,故名‘白崩’,水下如注站立片刻水湿可沿大腿滑泄而下。病情愈重则浓物愈多,热化愈炽者色愈黄、质也愈浓,痰湿重者质愈黏腻。甚者外阴部有黏胶状排泄物,但不搔痒。湿热、严重糜烂等各症,共同见证是带下色黄或淡黄,重则色褐或近紫,质粘浊,似血非血,或红白兼杂,称“赤白带”。淋漓不止量或多或少不定,其气秽臭、阴部瘙痒、甚者阴痛、分泌物呈豆渣样,痰湿重者质愈黏腻。
带下病在妇科并不是占着很重要的疾患,但却是很普遍很棘手、很难缠的疾病,每位妇女几乎曾经被困扰过。带下病的根治并不难,传统中医概以五脏内因辨证论治;而西医概以菌病,发炎着手。由于带下病的患者,常常是菌病发炎、伴以五脏内因体虚而致病。所以治疗时应着重消炎杀菌中兼以补虚固本,以期标本兼治,否则易导致带下病不孕的发生。目前最好的治疗方式是采用中医调理治疗的方法。中医治疗可以有效的解决了疾病的表面症状,又能够彻底的解决致病的根本因素。患者还可以根据具体情况适当的选择物理疗法。但是,患者要注意千万不能随便用药,要在专家的指导下进行。对于物理疗法,也有限度,不能过度,过度反而不利于病情,有损患者的健康。
发明内容
本发明所要解决的技术问题在于,西医对于本症一般大多数使用抗生素治疗,如青霉素、链霉素、红霉素、庆大霉素等,容易反复。带下病的根治并不难,传统中医概以五脏内因辨证论治;而西医概以菌病,发炎着手。由于带下病的患者,常常是菌病发炎、伴以五脏内因体虚而致病。所以治疗时应着重消炎杀菌中兼以补虚固本,以期标本兼治,否则易导致带下病不孕的发生。但是,中医讲究对症下药,个体差异明显,要在专家的指导下进行。对于物理疗法,也有限度,不能过度,过度反而不利于病情,有损患者的健康。本发明在传统医学的基础上结合多年临床经验,采用现代加工方法精心研制而成。本发明对原料药品的各有效成分科学配伍,能直达病灶,且见效快、副作用小、抑菌性强的制剂,能有效解除患者的痛苦,达到祛除疾病的目的。
为解决上述技术难题,本发明提供一种治疗妇女肝火湿热型带下的中药组合物,由内服药物和外用药物组成,所述内服药物原料药的重量份数可以为:土茯苓10~20份,鸡血藤10~20份,山茱萸10~20份,益母草10~20份,柴胡10~20份,丹参10~20份,莪术10~20份,蒲公英10~20份,黄芩10~20份,女贞子10~20份,覆盆子10~20份,龙胆草10~20份,穿心莲10~20份,丹皮10~20份,黄柏10~20份,车前子10~20份;
所述外用药物原料药的重量份数可以为:苦参10~20份,蛇床子10~20份,土茯苓10~20份,白鲜皮10~20份,艾叶10~20份,青黛10~20份,鱼腥草10~20份,冰片10~20份。
所述治疗妇女肝火湿热型带下的中药组合物,其所述内服药物原料药的重量份数还可以为:土茯苓10~15份,鸡血藤10~15份,山茱萸10~15份,益母草10~15份,柴胡10~15份,丹参10~15份,莪术10~15份,蒲公英10~15份,黄芩10~20份,女贞子10~20份,覆盆子10~20份,龙胆草10~20份,穿心莲10~20份,丹皮10~20份,黄柏10~20份,车前子10~20份;
所述外用药物原料药的重量份数还可以为:苦参10~15份,蛇床子10~15份,土茯苓10~15份,白鲜皮10~15份,艾叶10~15份,青黛10~15份,鱼腥草10~15份,冰片10~15份。
所述治疗妇女肝火湿热型带下的中药组合物,其所述内服药物原料药的重量份数也可以为:土茯苓10~20份,鸡血藤10~20份,山茱萸10~20份,益母草10~20份,柴胡10~20份,丹参10~20份,莪术10~20份,蒲公英10~20份,黄芩10~15份,女贞子10~15份,覆盆子10~15份,龙胆草10~15份,穿心莲10~15份,丹皮10~15份,黄柏10~15份,车前子10~15份;
所述外用药物原料药的重量份数也可以为:苦参15~20份,蛇床子15~20份,土茯苓15~20份,白鲜皮15~20份,艾叶15~20份,青黛15~20份,鱼腥草15~20份,冰片15~20份。
为解决上述技术问题,本发明还提供一种治疗妇女肝火湿热型带下的中药组合物的制备方法,其所述内服药物为胶囊剂的制备步骤包括:
a、取原料药放入乙醇中浸泡,热提取2次,为组分1;
b、药渣加水提取2次,浓缩过滤,为组分2;
c、将上述两种组分合并,浓缩,干燥成粉末装入胶囊。
所述步骤a中,可以取原料药加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分1。
所述步骤b中,可以将上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置,成为组分2。
所述步骤c中,可以将组分1和组分2的合并,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06;上述滤液经体积为10L的大孔吸附树脂柱吸附后,用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到药粉干燥后装入胶囊。
为解决上述技术问题,本发明再提供一种治疗妇女肝火湿热型带下的中药组合物的制备方法,所述外用药物为栓剂的制备步骤包括:将所述原料药除冰片与青黛外,其余加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,再将冰片、青黛用水蒸汽蒸馏法提取,得结晶物,混在上述得到的药膏里;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂,紫外线杀毒。
所述治疗妇女肝火湿热型带下外用栓剂的制备方法,其所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成子弹头状栓剂;所述棉栓为尾部带有棉线的棉栓。
所述治疗妇女肝火湿热型带下的中药组合物,其所述内服药物的剂型可以为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、丸剂、散剂、丹剂、溶液剂或注射剂;所述外用药物剂型可以为:喷雾剂、软膏、酊剂、膏剂、贴剂、中药洗剂、栓剂或灌肠剂。
本发明采用药栓和棉栓一体工艺,弥补了普通栓剂的不足,普通栓剂不能有效送达到阴道的深处。由于阴道的自净作用,当有异物存在时,会增加液体分泌,在短时间内将药物排除体外,既降低了疗效,又延长了疗程,增加费用又污染内衣裤。而本发明克服这一技术难题,制成的栓剂可充分发挥药物疗效,具有安全性好,可行性好的优点,能直达病灶,达到祛病目的。
本发明具有清热利湿、益气消瘀功效,用于治疗湿热阻滞导致的下腹痛、白带增多与色黄质稠、腰骶酸痛及神疲乏力等症状;本发明中含有穿心莲、鱼腥草等八味中药,山茱萸有固精涩肠作用,穿心莲有清热凉血、解毒消肿功效,蛇床子具有利湿祛风、消散瘀血功效;本发明各味用药清补结合、气血同治,最终达到促进气血和调、子宫内膜修复和提高机体免疫力的目的。研究也发现,本发明还具有抑菌、抗炎、镇痛及对血液流变学影响,这些功能均能对子宫内膜炎起到很好的作用,从而与抗生素形成良好的协同作用;临床中将两药联用能及时控制临床症状,减轻患者痛苦,同时也能显著提高治愈率,减少治愈后的复发。
具体实施方式
肝火湿热型带下:证见带下量多,色黄质粘稠,甚至黄绿如脓,味臭,或挟血,阴部肿痛瘙痒,口苦,小便黄赤,舌红,苔黄腻,脉弦数。肝火型白带表现在白带量多、颜色黄、有臭味、舌苔黄腻、月经量增多或延长。带下病的根治并不难,传统中医概以五脏内因辨证论治;而西医概以菌病,发炎着手。由于带下病的患者,常常是菌病发炎、伴以五脏内因体虚而致病。所以治疗时应着重消炎杀菌中兼以补虚固本,以期标本兼治,否则易导致带下病不孕的发生。目前最好的治疗方式是采用中医调理治疗的方法。中医治疗可以有效的解决了疾病的表面症状,又能够彻底的解决致病的根本因素。患者还可以根据具体情况适当的选择物理疗法。但是,患者要注意千万不能随便用药,要在专家的指导下进行。
带下是指妇女阴道分泌物明显增多,色、质、气味异常的症状。寒湿或湿热下注,或热毒浸淫,或脾肾阳气亏虚等常可见带下异常。带下一般见于女阴局部感染邪毒,或胞宫等的病变,最常见于带下病。但身体虚弱或痰湿内盛者亦可见带下量多。主症是阴道流出的粘稠液体增多,如涕如脓。兼见带下色黄,稠粘,如脓如涕,气秽臭,阴中瘙痒,小腹作痛,小便短赤,身热,口苦咽干,舌红,苔黄,脉滑数者,为湿热下注;带下色白或淡黄,无臭味,质粘稠,连绵不断,面色萎黄,食少便溏,神疲乏力,舌淡,苔白腻,脉濡弱者,为脾虚;带下色白,量多,质清稀,绵绵不断,小腹寒凉,腰部酸痛,小便频数清长,夜间尤甚,大便溏薄,舌淡,苔薄白,脉沉者,为肾虚。
本病发生的病因病机主要是脏腑功能失常,湿从内生;或下阴直接感染湿毒虫邪,致使湿邪损伤任带,使任脉不固,带脉失约,带浊下注胞中,流溢于阴窍,发为带下病。带下色白或淡黄、质粘稠、无臭气、绵绵不断,面色苍白、四肢不温、精神疲倦、纳少便溏,舌质淡,苔白腻,脉缓。带下病的辨证有虚实之分。临床以实证较多,尤其合并阴痒者更为多见。一般带下量多、色白,质清无臭者,属虚;带下量多,色、质异常有臭者,属实。本病的治疗以祛湿为主。脾虚者,健脾益气,升阳除湿;肾虚者,补肾固涩,佐以健脾除湿;湿热者,清热利湿;湿毒者,清热解毒利湿;感虫阴痒蚀烂者,必须配合阴道冲洗和纳药等外治法。治疗以清洗阴部并使用抗生素治疗。
以带下量多,或色、质、气味发生异常为主要表现的妇科常见病证。又称带下病。临床以白带、黄带、赤白带为多见,常伴有全身或局部症状。带下多由饮食不节,劳倦过度,或忧思气结,损伤脾气,或房室不节,年老久病,损伤肾气,脾肾不能运化水湿,带脉失约,以及恣食厚味酿生湿热,或情志不畅,肝郁脾虚,湿热下注,或感受湿毒、寒湿等引起。常见证型有:①脾虚湿盛型带下。证见带下量多,色白或淡黄,质稠,绵绵不断,面色不华,食少神疲,四肢不温,腹胀,便溏,舌淡苔白腻,脉缓弱。治宜健脾益气除湿,方用完带汤等。②肾虚寒湿型带下。证见带下量多,色白清冷,质稀薄,腰脊酸冷,尿频清长或夜尿多,便清溏,舌苔薄白,脉沉迟。治宜温肾固涩,方用内补丸、桂附止带汤等。③湿热湿毒型带下。证见带下量多,色黄质粘稠,甚至黄绿如脓,味臭,或挟血,阴部肿痛瘙痒,口苦,小便黄赤,舌红,苔黄腻,脉弦数。
本发明的目的,就是针对妇科疾病中盆腔炎的药物的疗效均不理想,见效较慢,对人体副作用大,对妇女身体危害较大,且易反复的缺点,发明生产一种见效快、副作用小、抑菌性强的药物,以解除患者的痛苦。本发明继承祖国的医学遗产,将中华医药发扬光大,利用满山遍野的中草药资源优势,研制一种特效、安全、方便、价廉、纯天然的中药制剂,用以治疗妇女的各种盆腔炎等常见妇科病,多发病,弥补西药毒副作用大,对妇女身体危害深等缺陷。本发明制备工艺简单,药物原料价格低廉,疗效好,能达到比较好的社会效果及经济利益。本发明具有活血化瘀、清利湿热的功效,用于气滞蕴结之盆腔炎,症见带下量多,下腹疼痛等症,同时适用于慢性盆腔炎、慢性附件炎、卵巢囊肿、阴道炎等常见病的治疗,效果显著。该药具有溶解快、释药迅速的优点,达到快速缓解症状和治疗的目的。
土茯苓甘淡,平。归经:肝经;胃经;脾经。功能:解毒,除湿,利关节。主治:治梅毒,淋浊,筋骨挛痛,脚气,疗疔疮,痈肿,瘰疬,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛。《本草正义》:土茯苓,利湿去热,能入络,搜剔湿热之蕴毒。其解d水银、轻粉毒者,彼以升提收毒上行,而此以渗利下导为务,故专治杨梅毒疮,深入百络,关节疼痛,甚至腐烂,又毒火上行,咽喉痛溃,一切恶症。
鸡血藤苦、甘,温。归肝、肾经。主治:活血舒筋;养血调经。主手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经;闭经。功用:补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛。《饮片新参》:去瘀血,生新血,流利经脉。治暑痧,风血痹症。《现代实用中药》:为强壮性之补血药,适用于贫血性之神经麻痹症,如肢体及腰膝酸痛,麻木不仁等。又用于妇女月经不调,月经闭止等,有活血镇痛之效。
山茱萸,主治心下邪气寒热,温中,逐寒温痹,去三虫,久服轻身有强阴益精、安五脏、通九窍、止小便淋沥之功;久服明目、强力长年。山茱萸,又名山芋肉、药枣、实枣儿、枣皮、肉枣等,为我国常用名贵中药材,应用历史悠久。它以其补力平和、壮阳而不助火,滋阴而不腻膈,收敛而不留邪等特殊功效被历代医学所喜用。张仲景以山茱萸为君创制了“金匮肾气丸”。据化学分析,山茱萸含有生理活性较强的山茱萸甙、酒石酸、没食子酸、苹果酸、树酯、鞣质和多种维生素等有效成分,具有增强免疫、抗炎、抗菌等药理作用,是中医临床中常用的一味药。
柴胡性味归经:性微寒、味苦、辛、归肝经、胆经,具疏肝利胆、疏气解郁、散火之功效。功能:透表泄热,疏肝解郁,升举阳气。主治:治感冒发热、寒热虚劳发热。小儿痘疹余热,面黄肌瘦腹部膨大,[3]疟疾,肝郁气滞,胸肋胀痛,脱肛,子宫脱落,月经不调。《本草正》:″柴胡,用此者用其凉散,平肝之热。其性凉,故解寒热往来,肌表潮热,肝胆火炎,胸胁痛结,兼治疮疡,血室受热;其性散,故主伤寒邪热未解,温病热盛,少阳头痛,肝经郁证。
莪术辛、苦,温。归肝、脾经。行气破血,消积止痛。用于燀瘕痞块,瘀血经闭,食积胀痛;早期宫颈癌。功效主治:破血行气止痛:本品功效与三棱相似,但温通力较大,可治疗血滞经闭腹痛、腹部包块、积聚。积散结:本品能行气消积止痛,用于饮食积滞、胸腹满闷作痛。破血祛瘀,妇女闭经,或痰湿淤血凝结而成的症瘕癖块。贾所学:“蓬术味辛性烈,专攻气中之血,主破积消坚,去积聚癖块,经闭血瘀,扑报疼痛。与三棱功用颇同,亦勿过服。”(《药品化义》)
女贞子,味甘苦、性凉,归肝肾经,具有滋补肝肾、益阴养血之功。现代医学研究证明,女贞子内含熊果酸、甘露醇、葡萄糖、脂肪油等,有强心、利尿和保肝作用,能使因化疗引起的白细胞下降数量升高,并对金黄色葡萄球菌、大肠杆菌有抑制作用。女贞子中含有齐墩果酸女贞子酸、女贞苷、熊果酸、硬脂酸、油酸、甘露醇、白桦脂醇、磷脂以及糖类如女贞子多糖、阿拉伯糖、葡萄糖等,还含有15种氨基酸,11种微量元素及挥发油等。研究认为女贞子有降血糖及降血脂并有抗动脉粥样硬化作用,还有抗菌、抗病毒作用,女贞子煎剂对金黄色葡萄球菌、福氏痢疾杆菌、伤寒杆菌、绿脓杆菌和大肠杆菌均有抑制作用。对B型腺病毒有中等度抑制作用。升高白细胞:女贞子及其成分制剂对血细胞均有一定影响,它对因化疗所致白细胞下降有升高作用。含女贞子的复方也有升白细胞作用。抗血栓作用:齐墩果酸可加快血小板细胞的流动性,减弱了血小板之间的碰撞,使之不易粘连和聚集,更不易在血管内膜沉积,减缓或防止血栓形成,又可降低脂质内膜的沉积,为防治老年人的血栓性疾病提供了部分实验依据。抗衰老提高免疫力:女贞子煎剂可使小鼠免疫器官胸腺、脾脏重量增加;明显提高小鼠血清溶血素抗体活性,对小鼠脾淋巴细胞产生白介素-2的影响具有双向调节作用。女贞子具有显著的免疫增强作用,清除自由基从而抗衰老。应用女贞子防治:心血管疾病、冠心病、高脂血症、糖尿病、血小板减少症、白细胞减少症,慢性肾炎、慢性支气管炎、顽固性失眠、慢性苯中毒、肿瘤、营养不良、免疫功能低下症、脂溢性皮炎
龙胆草:《本草纲目》记载:“性味苦,涩,大寒,无毒。主治骨间寒热、惊病邪气,继绝伤,定五脏,杀虫毒。”龙胆草性味甘,寒,功专清热燥湿,其泻肝胆实火作用甚强,并可息风止痉止痛。清热燥湿;泻肝定惊。湿热黄疸;小便淋痛;阴肿阴痒;湿热带下;肝胆实火之头胀头痛;目赤肿痛;耳聋耳肿;胁痛口苦;热病惊风抽搐。《医学启源》:以柴胡为主,草龙胆为使,治眼疾中必用之药也。治黄目赤肿,睛胀,瘀肉高起,痛不可忍。《主治秘诀》云:治下部风湿及湿热,脐下至足肿痛,寒湿脚气。《纲目》:疗咽喉痛,风热盗汗。相火寄在肝胆,有泻无补,故龙胆之益肝胆之气,正以其能泻肝胆之邪热也。但大苦大寒,过服恐伤胃中生发之气,反助火邪,亦久服黄连反从火化之义。
丹皮,中药名。为毛茛科植物牡丹干燥根皮。产于安徽、山东等地。秋季采挖根部,除去细根,剥取根皮,晒干。生用或炒用。《本草纲目》:“滋阴降火,解斑毒,利咽喉,通小便血滞。后人乃专以黄蘖治相火,不知丹皮之功更胜也。赤花者利,白花者补,人亦罕悟,宜分别之。”现代研究,所含牡丹酚及其以外的糖苷类成分均有抗炎作用;牡丹皮的甲醇提取物有抑制血小板作用;牡丹酚有镇静、降温、解热、镇痛、解痉等中枢抑制作用及抗动脉粥样硬化、利尿、抗溃疡等作用。
黄柏清热燥湿,泻火解毒,除骨蒸清虚热。用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《本草经疏》:黄檗,主五脏肠胃中结热。盖阴不足,则热始结于肠胃;黄瘅虽由湿热,然必发于真阴不足之人;肠痔漏,亦皆湿热伤血所致;泄痢者,滞下也,亦湿热干犯肠胃之病;女子漏下赤白,阴伤蚀疮,皆湿热乘阴虚流客下部而成;肤热赤起,目热赤痛口疮,皆阴虚血热所生病也。以至阴之气,补至阴之不足,虚则补之,以类相从,故阴回热解,湿燥而诸证自除矣。乃足少阴肾经之要药,专治明虚生内热诸证,功烈甚伟,非常药可比也。
车前子甘;淡;性微寒。归经:归肺经;肝经;肾经;膀胱经。功能:清热利尿;渗湿止泻;明目;祛痰。主治:主小便不利;淋浊带下;水肿胀满;暑湿泻痢;目赤障翳;痰热咳喘。《本草经集注》:主虚劳。《药性沦》:能去风毒,肝中风热,毒风冲眼目,赤痛障翳,脑痛泪出,去心胸烦热。《日华子本草》:通小便淋涩,壮阳。治脱精,心烦。下气。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。
蒲公英是一味常用的中药,其药用价值早已载入各种医书。它全草入药,含蒲公英甾醇、蒲公英赛醇、蒲公英苦素、咖啡酸、胆碱、菊糖等成分。性平味甘微苦。可清热解毒,消肿散结。《本草纲目》记载:“解食毒,散滞气,清热毒,化食毒,消恶肿、结核、疔肿。”蒲公英昧甘平,其性无毒。当是入肝入胃,解热凉血之要药。
穿心莲为爵床科植物穿心莲(Andrographis paniculata(Burm.f.)Nees)的全草或叶。又名春莲秋柳,一见喜,榄核莲、苦胆草、金香草、金耳钩、印度草,苦草等。味苦,性寒。归心、肺、大肠、膀胱经。有清热解毒、消炎、消肿止痛作用。主治细菌性痢疾、尿路感染、急性扁桃体炎、肠炎、咽喉炎、肺炎和流行性感冒等,外用可治疗疮疖肿毒、外伤感染等。《广西中草药》:止血凉血,拔毒生肌,治肺脓疡,口腔炎。
覆盆子植物可入药,有多种药物价值,其果实有补肾壮阳的作用。覆盆子油属于不饱和脂肪酸,可促进前列腺分泌苛尔蒙。功效:补肝益肾,固精缩尿,明目。以大鼠、兔的阴道涂片及内膜切片作治疗指标,覆盆子似有雌激素样作用。抑菌作用100%煎剂用平板打洞法,对葡萄球菌有抑制作用,对霍乱弧菌也有抑制作用。雌激素样作用大鼠、兔的阴道涂片及内膜切片等指标表明,覆盆子似有雌激素样作用。
益母草味辛苦、凉。活血、祛淤、调经、消水。治疗妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡。益母草碱性皮下注射有中枢抑制作用,MLD为0.4-0.6g/kg。兔静脉注射益母草碱1mg/kg,可见尿量显著增加。益母草碱在较高浓度时能使兔血悬液发生溶血作用。益母草碱水浸液用试管稀释法1∶13-1∶10,对许兰氏毛菌,羊毛样小孢子菌、红色表皮癣菌、星状奴卡氏菌均有抑制作用。益母草煎剂用平板纸片法,对大肠杆菌、志贺氏痢疾杆菌有抑制作用。益母草能去淤生新,活血调经,含有硒、锰等多种微量元素,能抗氧化、防衰老,具有相当不错的益颜美容、抗衰防老功效。
黄芩有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床应用抗菌比黄连还好,而且不产生抗药性。我们借助广谱抗菌作用强的特点,用在真菌培养杂菌感染特厉害,用黄芩提取液效果很好。《本草经疏》:黄芩,其性清肃,所以除邪:味苦所以燥湿;阴寒所以胜热,故主诸热。诸热者,邪热与遍热也,黄疸、肠僻、泄痢,皆湿热胜之病也,析其本,则诸病自瘳矣。
外用:
蛇床子性辛、苦,温;有小毒。归肾经。主治温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;外治外阴湿疹,妇人阴痒;滴虫性阴道炎,是妇科外用良药。《本草经疏》载:蛇床子,味苦平;《别录》辛甘无毒;今详其气味,当必兼温燥,阳也。故主妇人阴中肿痛,男子阴痿湿痒,除痹气,利关节,恶疮。《别录》温中下气,令妇人子服热,男子阴强,令人有子。盖以舌能除湿,温能散寒,辛能润肾,甘能益脾,故能除妇人男子一切虚寒湿所生病。寒湿既除,则病去,性能益阳,故能已疾,而又有补益也。
苦参性苦,寒。归心、肝、胃、大肠、膀胱经清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治霉菌性阴道炎,常与黄柏结合使用,是治疗阴道炎的外用妇科良药。
鱼腥草性微寒,味苦。归肺经、膀胱、大肠经。清热解毒;排脓消痈;利尿通淋。主治:热淋主肺痈吐脓;痰热喘咳;喉哦;热痢;痈肿疮毒;热淋。功效:清热解毒,利尿消肿。治肺炎,肺脓疡,热痢,疟疾,水肿,淋病,白带,痈肿,痔疮,脱肛,湿疹,秃疮,疥癣。《滇南本草》:治肺痈咳嗽带脓血,痰有腥臭,大肠热毒,疗痔疮。《纲目》:散热毒痈肿,疮痔脱肛,断痁疾,解硇毒。《医林纂要》:行水,攻坚,去瘴,解暑。疗蛇虫毒,治脚气,溃痈疽,去瘀血。
白鲜皮中药名。为芸香科多年生草本植物白鲜和狭叶白鲜的根皮。春、秋二季采挖根部,除去泥沙及粗皮,剥取根皮,切片,干燥。生用。具有清热燥湿,祛风解毒之功效。《药性论》:“治一切热毒风,恶风,风疮、疥癣赤烂,眉发脱脆,皮肌急,壮热恶寒;主解热黄、酒黄、急黄、谷黄、劳黄等。”现代研究,该品挥发油在体外有抗癌作用。
艾叶辛、苦,温,无毒;归肝、脾、肾经。散寒止痛,温经止血。用于少腹冷痛,经寒不调,宫冷不孕,吐血,衄血,崩漏经多,妊娠下血;外治皮肤瘙痒,脱皮。理气血,逐寒湿;温经,止血,安胎。治心腹冷痛,泄泻转筋,久痢,吐衄,下血,月经不调,崩漏,带下,胎动不安,痈疡,疥癣。《别录》:主灸百病。可作煎,止下痢,吐血,下部匿疮,妇人漏血。利阴气,生肌肉,辟风寒,使人有子。陶弘景:捣叶以灸百病,亦止伤血。
青黛性味:咸,寒。归经:入肝经、肺经、胃经。功能:清热,凉血消斑,解毒,清肝泻火,定惊。主治:治温病热盛,斑疹,吐血、咯血,小儿惊痫,疮肿,丹毒,蛇虫咬伤。《本草经疏》:“青黛,解毒除热,固其所长,古方多有用之于诸血证者,使非血分实热,而病生于阴虚内热,阳无所附,火气因虚上炎,发为吐衄咯唾等证,用之非宜。血得寒则凝,凝则寒热交作,胸膈或痛,愈增其病矣。”《本经逢原》:“青黛,泻肝胆,散郁火,治温毒发斑及产后热痢下重,《千金》蓝青丸用之,天行寒热头痛,水研服之。与蓝同类,而止血拔毒杀虫之功,似胜于蓝。又治噎膈之疾,取其化虫之力也。和溺白、冰片,吹片,吹口疳最效。”
冰片味辛、苦,微寒;归心、肝、肺经;清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。通诸窍,散郁火,去翳明目,消肿止痛,清热散毒,散火解毒。治乳腺结块,中风口噤,热病神昏,惊痫痰迷,气闭耳聋,喉痹,口疮,中耳炎,痈肿,痔疮,目亦翳膜,蛲虫病。《别录》:″妇人难产,取龙脑研末少许,以新汲水调服。″《唐本草》:″主心腹邪气,风湿积聚,耳聋。明目,去目赤肤翳。″《海药本草》:″主内外障眼,三虫,治五痔,明目,镇心,秘精。″
本发明内服丸剂的制备步骤为:取土茯苓1500g,鸡血藤1500g,山茱萸1500g,益母草1500g,柴胡1500g,丹参1500g,莪术1500g,蒲公英1500g,黄芩1500g,女贞子1500g,覆盆子1500g,龙胆草1500g,穿心莲1500g,丹皮1500g,黄柏1500g,车前子1500g,加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,用烘箱干燥后,成细粉,掺蜂蜜搓成丸剂。
本发明内服胶囊剂的制作过程为:取土茯苓1500g,鸡血藤1500g,山茱萸1500g,益母草1500g,柴胡1500g,丹参1500g,莪术1500g,蒲公英1500g,黄芩1500g,女贞子1500g,覆盆子1500g,龙胆草1500g,穿心莲1500g,丹皮1500g,黄柏1500g,车前子1500g,将原料晾晒,切成粗粒,然后浸泡于乙醇中2小时。然后加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分1。再将上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置,成为组分2。将组分1和组分2的合并,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06;上述滤液经体积为10L的大孔吸附树脂柱吸附后,用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到药粉干燥后装入胶囊。
本发明栓剂的制备方法:将苦参1500g,蛇床子1500g,土茯苓1500g,白鲜皮1500g,艾叶1500g,鱼腥草1500g,加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状;再将青黛1500g,冰片1500g用水蒸汽蒸馏法提取,得结晶物,混在上述得到的药膏里;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂,紫外线杀毒。所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成子弹头状栓剂;所述棉栓为尾部带有棉线的棉栓。所述栓剂的具体用法如下:将本发明药物栓剂除去塑料外壳,取出药栓,拉出尾部棉线,将药栓纳入阴道底部,每晚一次,棉线留在体外,次日晨起拉出棉栓,连续用药7天为一疗程。
本发明洗剂的制备步骤为:将苦参1200g,蛇床子1200g,土茯苓1300g,白鲜皮1300g,艾叶1300g,鱼腥草1300g,将所述原料药切成粗颗粒,颗粒物放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置。将青黛1200g与冰片1200g蒸馏汽化得结晶,干燥成粉末;再将上述两种提取液合并,减压浓缩相对密度为80℃时1.37的滤液,回收乙醇,将所得滤液调整比重到1.06,加入过筛结晶粉末后搅匀,制成药液,外用清洗。
毒理学试验:
试验例1:本发明急性毒性试验
一、试验材料:
动物:昆明种小鼠,体重21-24g,雌雄各半,山东大学生物试验室育种。药物:本发明内服胶囊剂。
二、方法:
1、LD50计算:采用改良寇氏法,将小鼠随机分成5组,每组10只,雌雄各半,将栓剂溶解,配成最大浓度,按小鼠最大允许容量给药,所给剂量按生药量依次为18,14.4,11.5,9.2,7.4(g.kg-1),在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml,治疗动物死亡情况。
2、最大耐受剂量测定(MTD值):取小鼠20只,雌雄各10只。将栓剂加蒸馏水溶解,配成最高浓度,按动物的最大耐受量,以注射灌喂器能抽动为准。在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml(每ml含生药0.36g),总药量为18g生药/kg.d,相当临床成人50Kg体重用量的300倍。给药后连续治疗7天。
三、试验结果:
在LD50计算中当用最大允许浓度和最大允许容量给予小鼠时(18g/Kg.d),未见小鼠死亡,即未测出LD50,只可求最大耐受剂量,在7天治疗期中,动物其食欲、活动、毛色、精神状态等皆正常,发育正常,未见有死亡。即选用相当于临床剂量的300倍药量,并无不良反应发生,表明急性毒性极小,MTD>18g/Kg.d。
试验例2:本发明急性皮肤刺激试验报告
1、实验目的:检测本发明栓剂对实验动物皮肤的刺激/腐蚀作用和强度
2、材料和方法:
2.1.受试物:名称:本发明栓剂(实施例3方法制得)
2.2.实验动物:壹级大耳白种家兔,10只,雌性,体重2.1-2.3kg;由青岛大学医学院生物系实验动物中心提供;
2.3.试验方法:
选用皮肤完好的健康家兔10只,于试验前24小时将其背部脊柱两侧被毛剪掉,去毛面积左、右各约4cm×4cm。试验时取受试物0.2ml涂于2.5cm×2.5cm的二层纱布上,敷贴于一侧去毛皮肤表面,油纸覆盖,胶布固定。另一侧皮肤作为空白对照。封闭4小时后,去除覆盖物,并用温水清洗去残留受试物,于去除受试物后的1、24和48小时治疗涂抹部位皮肤反应,并评分。
3、实验结果:实验动物皮肤未出现任何红斑,红肿,发炎现象。
4、小结:根据《消毒技术规范》(1999)中皮肤刺激反应评分标准判定,本发明软膏剂对动物皮肤刺激强度属无刺激性。
实施例3:阴道粘膜刺激试验结果
1.试验万法:
实验动物检疫3天后,选用18只上述健康家兔,随机分为三组,每组各6只,分别为:空白对照、赋形剂对照、本发明栓剂组(按应用液5倍浓度)。分别用适当大小的灭菌棉条浸以灭菌生理盐水和受试物置于赋形剂对照组和受试物组动物阴道内,与阴道粘膜接触6小时,24小时后处死动物。取出局部阴道组织,治疗病变情况。
2、试验结果:阴道粘膜刺激试验结果
实施例4:皮肤过敏试验结果
用本发明栓剂,进行诱导和激发接触试验,在24小时和48小时后治疗试验小鼠,均不见皮肤有红斑及水肿等现象,与阴性对照组无差异。结果表明,该栓剂对皮肤反应强度近于零,即无皮肤变态反应。
实施例5:长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约40平方厘米。洗净脱毛剂,治疗24小时后每组豚鼠分别涂本发明栓剂溶液0.2、0.4和0.8ml,分别含生药92、184和368mg,另一组涂溶媒0.8ml每日二次,连续30天,治疗豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
2、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用药组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。提示,本发明中药栓剂长期用药对局部皮肤及全身重要脏器均未见明显的毒性作用。
试验结果表明:本发明中药栓剂实验安全。该药对乙型链球菌、金黄色葡萄球菌、大肠杆菌的最小抑制浓度为1∶150,淋球菌为1∶150,白色念珠菌为1∶300,对1∶20稀释度时的杀灭时间为5分钟,1∶50时为10分钟,1∶100时为20分钟,1∶200时为40分钟,1∶400时为8小时。
临床试验:
1、一般资料
140例均系门诊女性患者,随机分成两组。治疗组70例(本发明内服外用)年龄最小者23岁,最大者56岁;病情最短者发病3日,最长者9年;白带中检有滴虫者54例。对照组70例(白带净胶囊,克霉唑栓,国药准字H20056830:广西恒拓集团仁盛制药有限公司)其中年龄最小者24岁,最大者55岁;病情最短5天,最长者发病7年;白带中检有滴虫者48例。
2治疗方法
2.1对比组组:取白带净胶囊,每次1粒,1天2次,克霉唑栓,1天1次塞入阴道深部,月经期停止使用,10天为1疗程。由医务人员用窥阴器扩张阴道,擦净阴道分泌物,将药置于阴道.然后取出窥阴器。用药期间每日清洁外阴,禁止性交,经期停药。
2.2治疗组:内服:土茯苓15g,鸡血藤12g,山茱萸13g,益母草12g,柴胡13g,丹参12g,莪术13g,蒲公英12g,黄芩13g,女贞子13g,覆盆子12g,龙胆草13g,穿心莲13g,丹皮13g,黄柏13g,车前子12g;
外用:苦参15g,蛇床子14g,土茯苓13g,白鲜皮14g,艾叶15g,青黛14g,鱼腥草14g,冰片14g。制成栓剂,每次1粒,1日1次,塞入阴道深部,10天为1疗程,月经期停止使用。由医务人员用窥阴器扩张阴道,擦净阴道分泌物,将药置于阴道.然后取出窥阴器。用药期间每日清洁外阴,禁止性交,经期停药。
3疗效标准:依据卫生部《新药指导原则》
痊愈:带下量、色、质、气味转为正常状态;全身症状好转,阴道局部症状消失;化验检查阴道清洁度1级。滴虫致病菌为阴性。显效:带下量由3级或2级转为1级,色、质、气性味恢复为正常;全身症状好转;化验检查阴道清洁度由3转2或1级,滴虫致病菌转为阴性。有效:带下量、色、质、气味明显好转;全身症状减轻;化验检查阴道清洁度由3级转为2级,致病菌滴虫时有出现。无效:带下量、色、质,气味无改善;全身症状和局部症状无改善;化验检查阴道清洁度无变化;致病菌滴虫未消失。以上疗效判断时间为用药一疗程。
4、治疗结果,见表1。
两组疗效统计
注P<0.001,两组有可比性。
5、讨论:《傅青主女科》云“夫带下俱是湿邪...”从临床上观察本病以阴部感染湿毒,或因经期、产后不洁,或因妇科手术消毒不严(包括人工流产、上环、取环等),阴部感染湿毒之邪所致。其临床主要症状为带下量明显增多,或带下色黄,甚者色黄如脓,或呈泡沫米治样,带下臭气,或伴有阴部搔痒不适,甚则红肿疼痛等。妇科检查取白带化验时阴道清洁度1。或检到致病菌。本发明土茯苓为君药,其味辛,咸,寒,有小毒,外用有解毒杀虫、拔毒生肌等作用,可治疗痈疽、溃烂、金疮出血、口疮等疾病;以柴胡、龙胆草、莪术、鸡血藤其味甘、寒,有祛除肝火,活血化瘀疗效。冰片、苦参为佐使药,苦参性甘,咸,凉,有清热解毒、杀虫防腐等作用;冰片性味辛,苦微寒,有消肿止痛的作用,两者合用配合有直接治疗因白带异常浸渍而致阴部红肿,或疼痛等兼症的作用。以上诸药配合共奏杀虫解毒、除湿止带之功,且有速效。
肝火湿热带下病是以带下量多,色黄或黄白相兼,粘稠秽臭,或浑浊如米泔,或呈泡沫状.阴户瘙痒,灼热疼痛,小便短赤,小腹坠胀,舌质红,苔黄腻,脉濡数为主证。临床上发病率高,病情顽固,缠绵难愈,带下病属妇科多发病,且以肝经湿热型为多见,可见于西医的滴虫性阴道炎及非特异性阴道炎。临床表现为带下量多,或伴外阴及阴道瘙痒,用带净止痒栓治疗效果显著,方中黄柏、苦参清热燥湿;蛇床子、艾叶除湿杀虫止痒;青黛清热,收敛生肌;冰片清热止痛,防腐止痒;诸药合用,共凑清热燥湿,杀虫止痒之功。
具体实施例:吴某,33岁,患者以前有人流史,带下痛经两年余。刮宫不彻底。近1年来黄白带下严重,味腥臭,腰腹坠痛,月事错前,色黯质浓,10d方干净,经前感觉会阴及腹部胀痛,状如临盆,苦涩不堪,须用止痛片方能缓解。患者有下腹痛、白带增多与色黄质稠、腰骶酸痛及神疲乏力等症状。患者舌红、苔薄黄,脉细数弦。妇科检查:慢性子宫内膜炎,阴道充血,宫颈下唇中糜,附件右侧增厚压痛,宫体大小正常,白带镜检:红血球(+),脓球(+++),证属湿浊之邪久滞带脉,瘀热互结成为带下,治宜燥湿,清热,利湿。使用如下配方:内服:土茯苓15g,鸡血藤12g,山茱萸13g,益母草12g,柴胡13g,丹参12g,莪术13g,蒲公英12g,黄芩13g,女贞子13g,覆盆子12g,龙胆草13g,穿心莲13g,丹皮13g,黄柏13g,车前子12g;
外用:苦参15g,蛇床子14g,土茯苓13g,白鲜皮14g,艾叶15g,青黛14g,鱼腥草14g,冰片14g。制成栓剂,每次1粒,1日1次,塞入阴道深部,10天为1疗程,月经期停止使用。用药期间每日清洁外阴,禁止性交,经期停药。
在月经期后,将本发明药物栓剂除去塑料外壳,取出药栓,拉出尾部棉线,将药栓纳入阴道深部,棉线留在体外,每晚1粒,次日晨起拉出棉栓,连续用药7天为一疗程。连用4个疗程。4个疗程见效。渐觉带下减少,色转浅淡,腰腹坠痛明显减轻,再使用本中药组合物3疗程渐愈。
Claims (10)
1.一种治疗妇女肝火湿热型带下的中药组合物,其特征在于,由内服药物和外用药物组成,
所述内服药物原料药的重量份数包括:土茯苓10~20份,鸡血藤10~20份,山茱萸10~20份,益母草10~20份,柴胡10~20份,丹参10~20份,莪术10~20份,蒲公英10~20份,黄芩10~20份,女贞子10~20份,覆盆子10~20份,龙胆草10~20份,穿心莲10~20份,丹皮10~20份,黄柏10~20份,车前子10~20份;
所述外用药物原料药的重量份数包括:苦参10~20份,蛇床子10~20份,土茯苓10~20份,白鲜皮10~20份,艾叶10~20份,青黛10~20份,鱼腥草10~20份,冰片10~20份。
2.根据权利要求1所述治疗妇女肝火湿热型带下的中药组合物,其特征在于,
所述内服药物原料药的重量份数包括:土茯苓10~15份,鸡血藤10~15份,山茱萸10~15份,益母草10~15份,柴胡10~15份,丹参10~15份,莪术10~15份,蒲公英10~15份,黄芩10~20份,女贞子10~20份,覆盆子10~20份,龙胆草10~20份,穿心莲10~20份,丹皮10~20份,黄柏10~20份,车前子10~20份;
所述外用药物原料药的重量份数包括:苦参10~15份,蛇床子10~15份,土茯苓10~15份,白鲜皮10~15份,艾叶10~15份,青黛10~15份,鱼腥草10~15份,冰片10~15份。
3.根据权利要求1所述治疗妇女肝火湿热型带下的中药组合物,其特征在于,
所述内服药物原料药的重量份数包括:土茯苓10~20份,鸡血藤10~20份,山茱萸10~20份,益母草10~20份,柴胡10~20份,丹参10~20份,莪术10~20份,蒲公英10~20份,黄芩10~15份,女贞子10~15份,覆盆子10~15份,龙胆草10~15份,穿心莲10~15份,丹皮10~15份,黄柏10~15份,车前子10~15份;
所述外用药物原料药的重量份数包括:苦参15~20份,蛇床子15~20份,土茯苓15~20份,白鲜皮15~20份,艾叶15~20份,青黛15~20份,鱼腥草15~20份,冰片15~20份。
4.一种如权利要求1~3中任一项所述治疗妇女肝火湿热型带下的中药组合物的制备方法,其特征在于,所述内服药物为胶囊剂的制备步骤包括:
a、取原料药放入乙醇中浸泡,热提取2次,为组分1;
b、药渣加水提取2次,浓缩过滤,为组分2;
c、将上述两种组分合并,浓缩,干燥成粉末装入胶囊。
5.根据权利要求4所述治疗妇女肝火湿热型带下的胶囊剂的制备方法,其特征在于,所述步骤a中,取原料药加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分1。
6.根据权利要求4所述治疗妇女肝火湿热型带下的胶囊剂的制备方法,其特征在于,所述步骤b中,上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置,成为组分2。
7.根据权利要求4所述治疗妇女肝火湿热型带下的胶囊剂的制备方法,其特征在于,所述步骤c中,将组分1和组分2的合并,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06;上述滤液经体积为10L的大孔吸附树脂柱吸附后,用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到药粉干燥后装入胶囊。
8.一种如权利要求1~3中任一项所述治疗妇女肝火湿热型带下的中药组合物的制备方法,其特征在于,所述外用药物为栓剂的制备步骤包括:将所述原料药除冰片与青黛外,其余加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,再将冰片、青黛用水蒸汽蒸馏法提取,得结晶物,混在上述得到的药膏里;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂,紫外线杀毒。
9.根据权利要求8中所述治疗妇女肝火湿热型带下外用栓剂的制备方法,其特征在于,所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成子弹头状栓剂;所述棉栓为尾部带有棉线的棉栓。
10.根据权利要求1~9中任一项所述治疗妇女肝火湿热型带下的中药组合物,其特征在于,所述内服药物的剂型为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、丸剂、散剂、丹剂、溶液剂或注射剂;所述外用药物剂型为:喷雾剂、软膏、酊剂、膏剂、贴剂、中药洗剂、栓剂或灌肠剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410620324.5A CN104274788A (zh) | 2014-11-05 | 2014-11-05 | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410620324.5A CN104274788A (zh) | 2014-11-05 | 2014-11-05 | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104274788A true CN104274788A (zh) | 2015-01-14 |
Family
ID=52250449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410620324.5A Pending CN104274788A (zh) | 2014-11-05 | 2014-11-05 | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104274788A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104707124A (zh) * | 2015-04-03 | 2015-06-17 | 杜卫卫 | 一种治疗慢性子宫内膜炎的中药制剂 |
CN104706953A (zh) * | 2015-04-03 | 2015-06-17 | 杜卫卫 | 一种治疗慢性子宫颈炎的中药制剂 |
CN105267432A (zh) * | 2015-10-12 | 2016-01-27 | 薛迎峰 | 治疗细菌性阴道炎的栓剂及其制备方法 |
CN106038802A (zh) * | 2016-06-21 | 2016-10-26 | 杨高林 | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 |
CN107684662A (zh) * | 2017-08-22 | 2018-02-13 | 唐家婷 | 一种妇女保健腰带 |
CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102078459A (zh) * | 2009-12-01 | 2011-06-01 | 陈子欣 | 一种治疗湿热带下的中药组合物 |
CN102357219A (zh) * | 2011-10-27 | 2012-02-22 | 陈仁德 | 一种治疗妇科湿热带下的中药制剂及其制备方法 |
-
2014
- 2014-11-05 CN CN201410620324.5A patent/CN104274788A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102078459A (zh) * | 2009-12-01 | 2011-06-01 | 陈子欣 | 一种治疗湿热带下的中药组合物 |
CN102357219A (zh) * | 2011-10-27 | 2012-02-22 | 陈仁德 | 一种治疗妇科湿热带下的中药制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
吴兰芬等: "浅谈苦参的临床应用", 《安徽中医临床杂志》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104707124A (zh) * | 2015-04-03 | 2015-06-17 | 杜卫卫 | 一种治疗慢性子宫内膜炎的中药制剂 |
CN104706953A (zh) * | 2015-04-03 | 2015-06-17 | 杜卫卫 | 一种治疗慢性子宫颈炎的中药制剂 |
CN105267432A (zh) * | 2015-10-12 | 2016-01-27 | 薛迎峰 | 治疗细菌性阴道炎的栓剂及其制备方法 |
CN106038802A (zh) * | 2016-06-21 | 2016-10-26 | 杨高林 | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 |
CN107684662A (zh) * | 2017-08-22 | 2018-02-13 | 唐家婷 | 一种妇女保健腰带 |
CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721131B (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
CN102847063B (zh) | 一种治疗气血两虚血瘀型糖尿病足的中药组合物及其制备方法 | |
CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN102178800B (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
CN104274788A (zh) | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
CN103751663A (zh) | 一种治疗肛周湿疹的中药外用制剂及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN102000164A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN104306498B (zh) | 一种治疗妇女肾虚寒湿型带下的中药组合物及其制备方法 | |
CN103720841B (zh) | 一种治疗慢性化脓性中耳炎的中药制剂及其制备方法 | |
CN103041247B (zh) | 一种治疗阴道炎的中药栓剂及其制备方法 | |
CN104306637A (zh) | 一种治疗妇女脾虚湿盛型带下的中药组合物及其制备方法 | |
CN101637552B (zh) | 一种防治慢性盆腔炎的中药组合物 | |
CN104587302A (zh) | 一种治疗急性阑尾炎的中药制剂 | |
CN105362839A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN103721138A (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN106038802A (zh) | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 | |
CN104352910A (zh) | 一种治疗妇女带下的中药外用栓剂及其制备方法 | |
CN104367946A (zh) | 一种治疗慢性子宫内膜炎的中药栓剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150114 |
|
RJ01 | Rejection of invention patent application after publication |